Humana (HUM) has told congressional staffers it will support moves that would curtail billing practices worth billions in extra payments, Anna Wilde Mathews and Christopher Weaver of The Wall Street Journal reports. Humana told staffers it is willing to back new limits on payments insurers can gain from diagnoses recorded by nurse practitioners, according to a one-page policy overview shared with the congressional staffers. Currently, insurers are paid more for covering sick patients, providing an incentive to record more diagnoses.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Trump Trade: Trump says Fed ‘must now’ lower rates after jobs report
- Trump conceals Medicaid cuts in effort to pass major tax bill, Bloomberg says
- Humana Reaffirms 2025 Earnings Guidance in June Meetings
- Humana price target lowered to $273 from $322 at Barclays
- Humana Secures $5 Billion Credit Agreement
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue